Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|May 15, 2023
<i>Antimicrobial Agents and Chemotherapy</i> Launches a New Section Focused on Innovative Antimicrobial Stewardship StudiesPranita D Tamma, Cesar A Arias, Ryan K Shields
Current Opinion in Infectious Diseases|November 3, 2015
Clinical perspectives on echinocandin resistance among Candida speciesRyan K Shields, M Hong Nguyen, Cornelius J Clancy
Journal of Fungi (Basel, Switzerland)|January 30, 2018
Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management StrategiesCornelius J Clancy, Ryan K Shields, M Hong Nguyen
Open Forum Infectious Diseases|October 20, 2025
Turning the Tide Against Carbapenem-resistant <i>Acinetobacter baumannii</i>: Advancing Care With Sulbactam-DurlobactamMichael Satlin, Ryan K Shields, Antoni Torres, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2019
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literatureAhmed Babiker, Lloyd Clarke, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
Is vancomycin ototoxicity a significant risk?Ryan K Shields, Jay L Martello, Brian A Potoski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2023
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex InfectionsRyan K Shields, David L Paterson, Pranita D Tamma
Expert Opinion on Pharmacotherapy|September 21, 2025
Novel beta-lactamase inhibitors with cefepime: where do they fit in clinical practice?Sunish Shah, Sahil Angelo, Brandon J Smith, et al.
Current Opinion in Pulmonary Medicine|September 8, 2025
New anti-infective approaches to treat airway infections in persons with cystic fibrosis and bronchiectasisJustin Massey, Ghady Haidar, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysisJovan Borjan, Kevin A Meyer, Ryan K Shields, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|May 15, 2023
<i>Antimicrobial Agents and Chemotherapy</i> Launches a New Section Focused on Innovative Antimicrobial Stewardship StudiesPranita D Tamma, Cesar A Arias, Ryan K Shields
Current Opinion in Infectious Diseases|November 3, 2015
Clinical perspectives on echinocandin resistance among Candida speciesRyan K Shields, M Hong Nguyen, Cornelius J Clancy
Journal of Fungi (Basel, Switzerland)|January 30, 2018
Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management StrategiesCornelius J Clancy, Ryan K Shields, M Hong Nguyen
Open Forum Infectious Diseases|October 20, 2025
Turning the Tide Against Carbapenem-resistant <i>Acinetobacter baumannii</i>: Advancing Care With Sulbactam-DurlobactamMichael Satlin, Ryan K Shields, Antoni Torres, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2019
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literatureAhmed Babiker, Lloyd Clarke, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
Is vancomycin ototoxicity a significant risk?Ryan K Shields, Jay L Martello, Brian A Potoski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2023
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex InfectionsRyan K Shields, David L Paterson, Pranita D Tamma
Expert Opinion on Pharmacotherapy|September 21, 2025
Novel beta-lactamase inhibitors with cefepime: where do they fit in clinical practice?Sunish Shah, Sahil Angelo, Brandon J Smith, et al.
Current Opinion in Pulmonary Medicine|September 8, 2025
New anti-infective approaches to treat airway infections in persons with cystic fibrosis and bronchiectasisJustin Massey, Ghady Haidar, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysisJovan Borjan, Kevin A Meyer, Ryan K Shields, et al.
Pageof 20